2026 Richard B. Mailman: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	73	2213	2022	1052	942	326	17940

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

2213

2022

1052

942

326

17940

Overview

Richard B. Mailman is affiliated with Pennsylvania State University in the United States. Their research primarily focuses on the fields of Medicine and Neuroscience, with significant contributions to subfields including Neurology, Cognitive Neuroscience, Cellular and Molecular Neuroscience, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in Richard B. Mailman's work include:

Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Receptor Mechanisms and Signaling
Functional Brain Connectivity Studies
Advanced Neuroimaging Techniques and Applications
Trace Elements in Health
Heavy Metal Exposure and Toxicity

Their recent publications reflect a focus on Parkinson's disease and brain activity, including:

"Decoupling of Global Brain Activity and Cerebrospinal Fluid Flow in Parkinson's Disease Cognitive Decline" (2021, Movement Disorders)
"Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage" (2022, Movement Disorders)
"Resting-state global brain activity affects early β-amyloid accumulation in default mode network" (2023, Nature Communications)
"The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study" (2020, Journal of Parkinson's Disease)
"D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa" (2020, European Journal of Pharmacology)

Frequent collaborators in their research include:

Xuemei Huang
Mechelle M. Lewis
Lan Kong
Guangwei Du
Yang Yang

Richard B. Mailman has published extensively in various venues, with notable frequency in:

UNC Libraries
bioRxiv (Cold Spring Harbor Laboratory)
Movement Disorders
Advances in Medical Education and Practice
Parkinsonism & Related Disorders

Best Publications

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Jonathan D. Urban;William P. Clarke;Mark Von Zastrow;David E. Nichols

1317
Citations
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

David A. Shapiro;Sean Renock;Elaine Arrington;Louis A. Chiodo

1249
Citations
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.

Cindy P Lawler;Cassandra Prioleau;Mechelle M Lewis;Chun Mak

582
Citations
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Richard B. Mailman;Vishakantha Murthy

395
Citations
Serotonergic basis of antipsychotic drug effects in schizophrenia

Jeffrey A Lieberman;Richard B Mailman;Gary Duncan;Lin Sikich

303
Citations
Behavioural assessment of mice lacking D1A dopamine receptors

D.R Smith;C.D Striplin;A.M Geller;R.B Mailman

300
Citations
Smoking duration, intensity, and risk of Parkinson disease

H. Chen;X. Huang;X. Guo;R. B. Mailman

280
Citations
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways

Jonathan D Urban;Gabriel A Vargas;Mark von Zastrow;Richard B Mailman

268
Citations
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.

Thomas J. Walsh;Hugh A. Tilson;Diane L. DeHaven;Richard B. Mailman

260
Citations
Simultaneous quantification of dopamine, 5-hydroxytryptaine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection

Clinton D. Kilts;George R. Breese;Richard B. Mailman

258
Citations
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.

Xuemei Huang;Honglei Chen;William C. Miller;Richard B. Mailman

245
Citations
GPCR functional selectivity has therapeutic impact

Richard B. Mailman

243
Citations
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.

C. B. Nemeroff;D. Luttinger;D. E. Hernandez;Richard Mailman

229
Citations
SCH-23390: A selective D1 dopamine antagonist with potent D2 behavioral actions

Richard B. Mailman;David W. Schulz;Mark H. Lewis;Laura Staples

207
Citations
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys

Jane R. Taylor;Matthew S. Lawrence;D.Eugene Redmond;John D. Elsworth

199
Citations
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Amy F.T. Arnsten;Ragy R. Girgis;David L. Gray;Richard B. Mailman

185
Citations
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study

Xuemei Huang;Robert D. Abbott;Robert D. Abbott;Robert D. Abbott;Helen Petrovitch;Richard B. Mailman

177
Citations
D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.

J. D. Elsworth;M. S. Lawrence;R. H. Roth;J. R. Taylor

172
Citations
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

Xuemei Huang;Alvaro Alonso;Xuguang Guo;David M. Umbach

172
Citations
Task specific influences of Parkinson’s disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries

M.M. Lewis;C.G. Slagle;A.B. Smith;Y. Truong

170
Citations
Quantitative Susceptibility Mapping of the Midbrain in Parkinson’s Disease

Guangwei Du;Tian Liu;Mechelle M. Lewis;Lan Kong

169
Citations
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor-and akinetic/rigid-predominant Parkinson's disease

Mechelle M. Lewis;Guangwei Du;Suman Sen;Suman Sen;Atsushi Kawaguchi

166
Citations
Long-Term Effects of Early Social Isolation in Macaca mulatta: Changes in Dopamine Receptor Function Following Apomorphine Challenge

Mark H. Lewis;John P. Gluck;Alan J. Beauchamp;Michael F. Keresztury

162
Citations